BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Broussard L, Howland A, Ryu S, Song K, Norris D, Armstrong CA, Song PI. Melanoma Cell Death Mechanisms. Chonnam Med J 2018;54:135-42. [PMID: 30288368 DOI: 10.4068/cmj.2018.54.3.135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Salgado MTSF, Fernandes E Silva E, Matsumoto AM, Mattozo FH, Amarante MCA, Kalil SJ, Votto APS. C-phycocyanin decreases proliferation and migration of melanoma cells: In silico and in vitro evidences. Bioorg Chem 2022;122:105757. [PMID: 35339928 DOI: 10.1016/j.bioorg.2022.105757] [Reference Citation Analysis]
2 Benitez MLR, Bender CB, Oliveira TL, Schachtschneider KM, Collares T, Seixas FK. Mycobacterium bovis BCG in metastatic melanoma therapy. Appl Microbiol Biotechnol 2019;103:7903-16. [PMID: 31402426 DOI: 10.1007/s00253-019-10057-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Valenti F, Falcone I, Ungania S, Desiderio F, Giacomini P, Bazzichetto C, Conciatori F, Gallo E, Cognetti F, Ciliberto G, Morrone A, Guerrisi A. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response. Int J Mol Sci 2021;22:3837. [PMID: 33917181 DOI: 10.3390/ijms22083837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Couto GK, Segatto NV, Oliveira TL, Seixas FK, Schachtschneider KM, Collares T. The Melding of Drug Screening Platforms for Melanoma. Front Oncol 2019;9:512. [PMID: 31293965 DOI: 10.3389/fonc.2019.00512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wu X, Yang Y, Xiang L, Zhang C. The fate of melanocyte: Mechanisms of cell death in vitiligo. Pigment Cell Melanoma Res 2021;34:256-67. [PMID: 33346939 DOI: 10.1111/pcmr.12955] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhou M, Yu X, Jing Z, Wu W, Lu C. Overexpression of microRNA‑21 inhibits the growth and metastasis of melanoma cells by targeting MKK3. Mol Med Rep 2019;20:1797-807. [PMID: 31257538 DOI: 10.3892/mmr.2019.10408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
7 Couto GK, Pacheco BS, Borba VM, Junior JCR, Oliveira TL, Segatto NV, Seixas FK, Acunha TV, Iglesias BA, Collares T. Tetra-cationic platinum(II) porphyrins like a candidate photosensitizers to bind, selective and drug delivery for metastatic melanoma. J Photochem Photobiol B 2020;202:111725. [PMID: 31790880 DOI: 10.1016/j.jphotobiol.2019.111725] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
8 Mercogliano MF, Bruni S, Mauro F, Elizalde PV, Schillaci R. Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers (Basel) 2021;13:564. [PMID: 33540543 DOI: 10.3390/cancers13030564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
10 Kumari M, Kamat S, Jayabaskaran C. Usnic acid induced changes in biomolecules and their association with apoptosis in squamous carcinoma (A-431) cells: A flow cytometry, FTIR and DLS spectroscopic study. Spectrochim Acta A Mol Biomol Spectrosc 2022;274:121098. [PMID: 35257985 DOI: 10.1016/j.saa.2022.121098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Chamcheu JC, Roy T, Uddin MB, Banang-Mbeumi S, Chamcheu RN, Walker AL, Liu YY, Huang S. Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy. Cells 2019;8:E803. [PMID: 31370278 DOI: 10.3390/cells8080803] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 15.7] [Reference Citation Analysis]
12 Mannsåker TA, Hoang T, Aasen SN, Bjørnstad OV, Parajuli H, Sundstrøm T, Thorsen FA. Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways. Int J Mol Sci 2021;22:12296. [PMID: 34830178 DOI: 10.3390/ijms222212296] [Reference Citation Analysis]
13 Ahmed RL, Shaughnessy DP, Knutson TP, Vogel RI, Ahmed K, Kren BT, Trembley JH. CDK11 Loss Induces Cell Cycle Dysfunction and Death of BRAF and NRAS Melanoma Cells. Pharmaceuticals (Basel) 2019;12:E50. [PMID: 30987032 DOI: 10.3390/ph12020050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
14 Maxian T, Gerlitz L, Riedl S, Rinner B, Zweytick D. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma. Int J Mol Sci 2021;22:8469. [PMID: 34445175 DOI: 10.3390/ijms22168469] [Reference Citation Analysis]
15 Dhanyamraju PK, Rotimi S, Bhattacharya P, Patel TN. Revisiting the melanomagenic pathways and current therapeutic approaches. Mol Biol Rep. [DOI: 10.1007/s11033-022-07412-2] [Reference Citation Analysis]
16 Trisciuoglio D, Del Bufalo D. New insights into the roles of antiapoptotic members of the Bcl-2 family in melanoma progression and therapy. Drug Discov Today 2021;26:1126-35. [PMID: 33545382 DOI: 10.1016/j.drudis.2021.01.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Mîndrilă I, Osman A, Mîndrilă B, Predoi MC, Mihaiescu DE, Buteică SA. Phenotypic Switching of B16F10 Melanoma Cells as a Stress Adaptation Response to Fe3O4/Salicylic Acid Nanoparticle Therapy. Pharmaceuticals (Basel) 2021;14:1007. [PMID: 34681232 DOI: 10.3390/ph14101007] [Reference Citation Analysis]
18 Falcone I, Conciatori F, Bazzichetto C, Ferretti G, Cognetti F, Ciuffreda L, Milella M. Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy. Cancers (Basel) 2020;12:E2870. [PMID: 33036192 DOI: 10.3390/cancers12102870] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
19 Liu W, Stachura P, Xu HC, Umesh Ganesh N, Cox F, Wang R, Lang KS, Gopalakrishnan J, Häussinger D, Homey B, Lang PA, Pandyra AA. Repurposing the serotonin agonist Tegaserod as an anticancer agent in melanoma: molecular mechanisms and clinical implications. J Exp Clin Cancer Res 2020;39:38. [PMID: 32085796 DOI: 10.1186/s13046-020-1539-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
20 Cardillo F, Bonfim M, da Silva Vasconcelos Sousa P, Mengel J, Ribeiro Castello-Branco LR, Pinho RT. Bacillus Calmette-Guérin Immunotherapy for Cancer. Vaccines (Basel) 2021;9:439. [PMID: 34062708 DOI: 10.3390/vaccines9050439] [Reference Citation Analysis]
21 Park C, Lee H, Hwangbo H, Ji SY, Kim MY, Kim SY, Hong SH, Kim GY, Choi YH. Ethanol Extract of Hizikia fusiforme Induces Apoptosis in B16F10 Mouse Melanoma Cells through ROS-Dependent Inhibition of the PI3K/Akt Signaling Pathway. Asian Pac J Cancer Prev 2020;21:1275-82. [PMID: 32458633 DOI: 10.31557/APJCP.2020.21.5.1275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]